(PharmaNewsWire.Com, April 29, 2020 ) The global Healthcare IT Consulting Market is expected to reach 45.42 Billion by 2022 from USD 18.38 Billion in 2017, at a CAGR of 19.8%. The growth of the market is attributed to the growing digitization in healthcare, rapidly changing HCIT landscape, government support for healthcare IT solutions, growing HCIT expenditure, lack of skilled IT professionals in the healthcare industry, growing venture capital investments in health IT, and the need for data security. Cloud consulting, emerging markets, increasing consolidation in healthcare, and small rural hospitals are expected to offer significant growth opportunities for players in the coming years.
Healthcare application analysis, design, and development segment to dominate the market in 2017
Based on type, the global HCIT consulting services market is segmented into HCIT strategy and project/program management; healthcare application analysis, design, and development; HCIT integration and migration; HCIT change management; healthcare/medical system & security set-up and risk assessment; healthcare enterprise reporting and data analytics services; production go-live/post go-live support; healthcare business process management; regulatory compliance; and others consulting services. In 2017, the healthcare application analysis, design, and development segment is expected to account for the largest share of the global HCIT consulting services market. The growth of this segment can be attributed to the fact that IT application analysis, design, and development form the major component of all IT solution implementation projects. Every healthcare facility has different requirements, which need careful designing, development, and implementation of customized solutions.
Based on end user, the healthcare payers segment is projected to register the highest CAGR
Based on end user, the market is segmented into healthcare providers, payers, and other end users. In 2017, healthcare payers segment is expected to witness the highest growth during the forecast period. The high growth rate of this segment can be attributed to factors like growing adoption of healthcare IT solutions by private and public payers, growing need for insurance payers to comply with various federal and regional laws and regulations, and growing focus of payers on reforming their business models for improved patient care delivery.
North America to dominate the market followed by Europe
In 2017, North America is expected to account for the largest share of the market. The large market share of the North American market is attributed to the factors such as government initiatives to enhance adoption of HCIT solutions, increasing government expenditure on HCIT, changing and stringent legislative requirements and accreditations necessary for healthcare IT solutions, growing hospital consolidations, and the presence of a large number of IT solutions and services companies.
In 2017, Europe is expected to hold the second largest share in this market. Factors such as government initiatives in European countries for eHealth technologies, the need for multi-country integration regarding health information, and growing demand for improving the quality of care through effective utilization of healthcare IT solutions are expected to drive the growth of the market in this region.
The global HCIT consulting services market is highly fragmented with several big and small players. Prominent players in the market include Accenture plc (Ireland), Cognizant Technology Solutions Corporation (U.S.), Deloitte Touche Tohmatsu Limited (U.S.), Cerner Corporation (U.S.), Siemens Healthineers (Germany), McKesson Corporation (U.S.), Epic Systems Corporation (U.S.), IBM Corporation (U.S.), General Electric Company (U.S.), Tata Consultancy Services Limited (India), Koninklijke Philips N.V. (Netherlands), NTT DATA Corporation (Japan), Infor Inc. (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), and Oracle Corporation (U.S.).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
